September 10, 2025BiosensorsOpen Access

Portable Point-of-Care Device for Dual Detection of Glucose-6-Phosphate Dehydrogenase Deficiency and Hemoglobin in Low-Resource Settings

View Full Paper

Ask AI

Bookmark

The MyG6PD device reliably detects G6PD deficiency, improving safety in administering oxidative drugs.
It demonstrated excellent accuracy with bias under ±15% and precision below 15% across varying activity levels.
This point-of-care tool supports use in decentralized settings, reducing the need for extensive training to operate.
Cost-effective consumables enable potential for large-scale deployment, improving accessibility in high-risk regions.

Discussion

No takes yet. Share an insight, caveat, or question.

Assessment shows accurate hemoglobin levels and G6PD enzyme activity in low-resource areas, suggesting vital implications for patient care.

Taha et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Assessment shows accurate hemoglobin levels and G6PD enzyme activity in low-resource areas, suggesting vital implications for patient care.